BioCatalyst

Lutetium (177Lu) rhPSMA-10.1 Injection, 18F-rhPSMA-7.3 injection (in phase 1 only) — catalyst calendar

1 verified catalyst event(s) referencing Lutetium (177Lu) rhPSMA-10.1 Injection, 18F-rhPSMA-7.3 injection (in phase 1 only), each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-27
in 2mo
ESTIMATED
 READOUT
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Phase 1/2 · Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
 Blue Earth Therapeutics Ltd Lutetium (177Lu) rhPSMA-10.1 Injection, ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.